Timing of cataract surgery in patients with giant cell arteritis
Autor: | Joseph W Fong, Joseph G. Chacko |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
genetic structures medicine.medical_treatment Giant Cell Arteritis Cataract Prednisone Biopsy medicine Humans Optic Neuropathy Ischemic Aged Retrospective Studies medicine.diagnostic_test business.industry Retrospective cohort study Perioperative Cataract surgery medicine.disease eye diseases Sensory Systems Surgery Ophthalmology Giant cell arteritis Cohort Current Procedural Terminology Female business medicine.drug |
Zdroj: | Journal of Cataract and Refractive Surgery. 47:83-86 |
ISSN: | 1873-4502 0886-3350 |
DOI: | 10.1097/j.jcrs.0000000000000392 |
Popis: | Purpose To determine a safe timeframe and parameters for performing cataract surgery following diagnosis and treatment of giant cell arteritis (GCA). Setting Single institution in the United States. Design Retrospective chart review. Methods This retrospective study used ICD-9/10 and Current Procedural Terminology codes to identify all patients with biopsy-proven GCA who underwent cataract surgery from 2005 to 2019 at a single institution. Excluded from the study were patients whose date of biopsy diagnosis or dose of corticosteroids at the time of cataract surgery was unknown. Results Chart review identified 10 patients (15 eyes) that met inclusion criteria; 80% of patients were female, and mean age was 74.4 years. Two patients had a history of arteritic ischemic optic neuropathy. There were no perioperative or postoperative complications in the 15 eyes that underwent cataract surgery with varying doses of prednisone at the time of surgery (1 to 25 mg daily prednisone +/- 10 to 25 mg weekly methotrexate; median prednisone dose of 10.75 mg) and varying time from biopsy diagnosis of GCA to surgery of at least 7 months (median 13.75 months). Conclusions Cataract surgery appeared safe for GCA patients on varying doses of prednisone at time of surgery at least 7 months from time of biopsy diagnosis. There is a need for a larger cohort of data from neuro-ophthalmologists and cataract surgeons nationally to establish guidelines for safe cataract surgery in GCA patients. |
Databáze: | OpenAIRE |
Externí odkaz: |